A detailed history of International Biotechnology Trust PLC transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, International Biotechnology Trust PLC holds 179,702 shares of ACAD stock, worth $2.92 Million. This represents 1.27% of its overall portfolio holdings.

Number of Shares
179,702
Previous 151,000 19.01%
Holding current value
$2.92 Million
Previous $3.62 Million 3.54%
% of portfolio
1.27%
Previous 1.13%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$20.84 - $33.47 $598,149 - $960,655
28,702 Added 19.01%
179,702 $3.74 Million
Q2 2023

Aug 08, 2023

SELL
$17.8 - $25.65 $1.16 Million - $1.67 Million
-65,000 Reduced 30.09%
151,000 $3.62 Million
Q1 2023

May 18, 2023

BUY
$16.32 - $20.92 $1.89 Million - $2.43 Million
116,000 Added 116.0%
216,000 $4.07 Million
Q4 2022

Feb 01, 2023

BUY
$14.2 - $18.63 $1.42 Million - $1.86 Million
100,000 New
100,000 $1.59 Million
Q2 2021

Aug 11, 2021

SELL
$19.4 - $27.42 $1.15 Million - $1.63 Million
-59,514 Closed
0 $0
Q1 2021

May 17, 2021

SELL
$25.02 - $54.99 $10.7 Million - $23.5 Million
-426,486 Reduced 87.75%
59,514 $1.53 Million
Q3 2020

Dec 01, 2020

BUY
$36.42 - $57.0 $6.59 Million - $10.3 Million
181,000 Added 59.34%
486,000 $20 Million
Q2 2020

Jul 14, 2020

SELL
$39.26 - $52.73 $1.26 Million - $1.69 Million
-32,000 Reduced 9.5%
305,000 $14.7 Million
Q1 2020

May 18, 2020

BUY
$31.65 - $46.87 $31,650 - $46,870
1,000 Added 0.3%
337,000 $14.2 Million
Q4 2019

May 18, 2020

BUY
$36.21 - $51.4 $9.7 Million - $13.8 Million
268,000 Added 394.12%
336,000 $14.4 Million
Q3 2019

Nov 14, 2019

BUY
$22.22 - $44.01 $333,300 - $660,150
15,000 Added 28.3%
68,000 $2.45 Million
Q2 2019

Aug 14, 2019

SELL
$23.32 - $28.12 $5.04 Million - $6.07 Million
-216,000 Reduced 80.3%
53,000 $1.42 Million
Q1 2019

May 14, 2019

SELL
$16.17 - $27.38 $211,261 - $357,719
-13,065 Reduced 4.63%
269,000 $7.22 Million
Q4 2018

Feb 14, 2019

BUY
$14.32 - $22.92 $3.11 Million - $4.98 Million
217,065 Added 333.95%
282,065 $3.58 Million
Q3 2018

Nov 14, 2018

BUY
$13.03 - $21.81 $674,954 - $1.13 Million
51,800 Added 392.42%
65,000 $1.04 Million
Q3 2018

Nov 13, 2018

BUY
$13.03 - $21.81 $171,996 - $287,892
13,200 New
13,200 $4.55 Million
Q2 2018

Aug 13, 2018

SELL
$15.07 - $22.34 $644,589 - $955,548
-42,773 Closed
0 $0
Q1 2018

May 15, 2018

SELL
$22.47 - $32.33 $6.54 Million - $9.41 Million
-291,000 Reduced 87.19%
42,773 $961,000
Q4 2017

Mar 02, 2018

BUY
$26.84 - $39.14 $2.5 Million - $3.64 Million
93,000 Added 38.63%
333,773 $10 Million
Q3 2017

Mar 02, 2018

BUY
$29.49 - $38.37 $3.04 Million - $3.95 Million
103,000 Added 74.76%
240,773 $9.07 Million
Q2 2017

Mar 02, 2018

BUY
N/A
88,122 Added 177.48%
137,773 $3.84 Million
Q1 2017

Mar 02, 2018

SELL
N/A
-807 Reduced 1.6%
49,651 $1.71 Million
Q4 2016

Mar 02, 2018

BUY
N/A
50,458
50,458 $1.46 Million

Others Institutions Holding ACAD

About ACADIA PHARMACEUTICALS INC


  • Ticker ACAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 161,843,008
  • Market Cap $2.63B
  • Description
  • ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...
More about ACAD
Track This Portfolio

Track International Biotechnology Trust PLC Portfolio

Follow International Biotechnology Trust PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of International Biotechnology Trust PLC, based on Form 13F filings with the SEC.

News

Stay updated on International Biotechnology Trust PLC with notifications on news.